1Jones A, Dhamrait SS, Payne JR, et al. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension[J]. Hypertension, 2003,42:500-506
2Hingorani AD, Jia H, Stevens P, et al. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition[J]. J Hypertens, 1995,13:1602-1609
3Kurland L, Melhus H, Karlsson J, et al. Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin Ⅱ receptor type 1 antagonist treatment in hypertensive patients[J]. J Hypertens, 2001,19:1783-1787
4Staessen JA, Ginocchio G, Wang JG, et al. Genetic variability in the renin-angiotensin system: prevalence of alleles and genotypes[J]. J Cardiovasc Risk, 1997,4:401-422
5TROTTA R,DONATI M B,IACOVIELLO L. Trends in pharmacogenomics of drugs acting on hypertension [ J ]. Pharmacological Research, 2004,49 (4) : 351 - 356.
6SCHELLEMAN H, KLUNGEL O H, VAN DULJN C M, et al. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy [ J ]. Ann Phar, 2006,40 ( 2 ) : 212 - 218.
7JONES A, DHAMRAIT S S, PAYNE J R, et al. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension [ J ]. Hypertension, 2007,42 ( 4 ) : 500 - 506.
